December 17, 2018
WELLESLEY, Mass., Dec. 17, 2018 - Due to the increased prevalence of diseases, such as cancer and metabolic diseases, the healthcare and pharmaceutical industries have worked to develop efficient and precise diagnostic tools and targeted therapies. CT scanners are fundamental radiological tools that aid in diagnosing both cardiovascular and neurological disorders, as well as cancer.
In 2018 the CT scanners market was valued at $8.2 billion and is expected to reach $10.4 billion by 2022 at a compound annual growth rate (CAGR) of 4.9%, according to the report “Global Markets for CT Scanners.”
Major players in the industry mentioned in this report include Siemens Healthineers (SMMNY), Toshiba America Medical Systems (acquired by Canon Inc.), Philips Medical Systems BV, Hitachi Medical Systems and Neusoft Medical Systems Co. Ltd, and many others.
“Unlike other medical imaging techniques, such as conventional X-ray imaging, CT allows greater distinguishing of soft tissue such as fat and liver,” said report author Shalini Shahani Dewan. “It makes CT scans suitable for a wider range of applications such as oncology, neurological, cardiovascular, coronary CT angiography and pediatric imaging.”
The Need for CT Scanners in Emerging Economies
In the emerging economies a rise in research expenditures, unhealthy lifestyles and the need for effective diagnostic tools have driven the demand in the CT scanner market. China and India remain promising markets for the healthcare industry. Asian countries are sought out markets among various companies for homogeneous tumor profiles, and China and India have a large number of hospitals and diagnostic centers throughout the region.
Editors/reporters requesting analyst interviews should contact Eric Surber at email@example.com.
Global Markets for CT Scanners( HLC024B )
Publish Date: Dec 2018